Science Explorer Back to mapMap
Discussion
Researcher · AMAG Pharmaceuticals (United States) · United States

Marie-Aude Guié

Marie-Aude Guié publishes mostly in Molecular Biology, Organic Chemistry and Immunology, on topics such as Chemical Synthesis and Analysis, Protein Degradation and Inhibitors and Click Chemistry and Applications.

OpenAlex
World rank
#985,592
of 7,710,434 ranked researchers
Rank in United States
#322,426
of 1,627,098
Works
34
Citations
1.1k
Citations per work
31.0
h-index
16
i10-index 18Top 46% in Molecular Biology
Marie-Aude Guié

What does Marie-Aude Guié research?

Marie-Aude Guié's work is mostly in Biochemistry, Genetics and Molecular Biology (55%), Chemistry (8%), Medicine (7%).

Life Sciences: 20 works · 59.8% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 54.6% of their workMolecular Biology: 17 works · 50.5% of their workCell Biology: 1 works · 4.1% of their workImmunology and Microbiology: 2 works · 5.2% of their workImmunology: 2 works · 5.2% of their workEverything else: 8 works · 24.8% of their workPhysical Sciences: 3 works · 8.2% of their workChemistry: 3 works · 8.2% of their workOrganic Chemistry: 3 works · 8.2% of their workHealth Sciences: 2 works · 7.2% of their workMedicine: 2 works · 7.2% of their workOncology: 1 works · 4.1% of their workPharmacology: 1 works · 3.1% of their workTHEIR WORKMarie-Aude Guié34works
Life Sciences60%Physical Sciences8%Health Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1954.6%
    2. Immunology and Microbiology25.2%
  2. Everything else824.8%
    1. Chemistry38.2%
    1. Medicine27.2%
  1. 1Molecular Biology50% of their works
  2. 2Organic Chemistry8% of their works
  3. 3Immunology5% of their works
  4. 4Oncology4% of their works
  5. 5Cell Biology4% of their works
  6. 6Pharmacology3% of their works

Research topics

Which keywords describe Marie-Aude Guié's research?

The keywords of their largest research topics: Drug Discovery, Foldamers, Peptide Synthesis, BET Bromodomains, PROTACs, Click Chemistry, Copper-Catalyzed Cycloaddition and ADAR Deaminases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Drug Discovery132 topics
  2. Foldamers81 topic
  3. Peptide Synthesis81 topic
  4. BET Bromodomains61 topic
  5. PROTACs61 topic
  6. Click Chemistry51 topic
  7. Copper-Catalyzed Cycloaddition51 topic
  8. ADAR Deaminases31 topic
  9. DNA31 topic
  10. Endoplasmic Reticulum31 topic
  11. Protein31 topic
  12. RNA Editing31 topic
  13. Ribosome31 topic
  14. Stress31 topic
  15. Structure31 topic
  16. Topoisomerases31 topic
  17. Translation31 topic

Where does Marie-Aude Guié work?

Marie-Aude Guié's main affiliation in the publication record is AMAG Pharmaceuticals (United States), United States.

How many publications and citations does Marie-Aude Guié have?

OpenAlex counts 34 works and 1,054 citations for Marie-Aude Guié, an h-index of 16, ranking #985,592 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marie-Aude Guié. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.